Results 71 to 80 of about 940 (155)

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Rheumatology &Autoimmunity, Volume 6, Issue 1, Page 60-62, March 2026.
Lilian Vasaitis, Lena Blomstrand, Tatjana Pandzic, Miklos Gulyas, Panagiotis Baliakas, Viktor Ljungström   +5 more
wiley   +1 more source

VEXAS syndrome in a nutshell

, 2023
 
openaire   +2 more sources

Unveiling VEXAS Syndrome: When Skin Manifestations and Monoclonal Gammopathy Precede Myeloid‐Lineage Hematologic Abnormality

ACR Open Rheumatology
VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome is a rare disorder caused by somatic UBA1 gene mutations, characterized by autoinflammation and hematologic abnormalities, particularly affecting myeloid‐lineage progenitors ...
Laura Di Centa, Simone Longhino, Valeria Manfrè, Stefania Sacco, Luca Quartuccio   +4 more
doaj   +1 more source

Think VEXAS: a case report of Vexas syndrome

Journal of Rare Diseases
AbstractVEXAS syndrome is a rare auto-inflammatory disorder characterized by heterogeneous inflammatory and hematologic features. First identified in 2020, it predominantly affects men over the age of 50. Clinical manifestations commonly include recurrent fever, weight loss, skin lesions, and diverse inflammatory presentations across multiple organ ...
T. Najdi, S. Karaa
openaire   +2 more sources

VEXAS syndrome: Focus on dermatological manifestations and their histopathological correlate

JEADV Clinical Practice
Background VEXAS ‘Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome’ is a rare autoinflammatory syndrome, first described in October 2020 by Beck et al.
Sofie Engelen, Anne‐Catherine Dens, Frederik Staels, Rik Schrijvers, Daniel Blockmans, Steven Vanderschueren, Albrecht Betrains, F. J. Sherida H. Woei‐A‐Jin, Arno Vanstapel, Franscesca Bosisio, Petra De Haes   +10 more
doaj   +1 more source

ORAL COMMUNICATION | Intravenous immunoglobulin for cutaneous features of VEXAS syndrome: a case report

Italian Journal of Medicine
Background. VEXAS syndrome is an autoinflammatory disorder caused by somatic mutations in the UBA1 gene and is characterized by severe inflammation and hematologic disorders with systemic manifestations.
G. Duro, M. Quarta, E. Chiara, N. Di Meo, M. Poiani, M. L. Urban, F. Zaja, F. Zanconati, V. Zerbato, G. Emmi   +9 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

VEXAS without vacuoles: Linking genotype to phenotype

eJHaem
Introduction VEXAS syndrome is a rare condition characterized by somatic mutations in the ubiquitin‐like modifier activating enzyme 1 (UBA1) gene and a constellation of clinical/morphologic findings, including the presence of cytoplasmic vacuoles within ...
Sara Zhukovsky, Anton Rets, Tawnie Braaten, Ami B. Patel   +3 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report

BMC Nephrology
Background Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is caused by mutations in the ubiquitin-activating enzyme1 (UBA1) gene and characterised by an overlap between autoinflammatory and haematologic disorders.
Natsuki Fukuda, Daisuke Kanai, Kaoru Hoshino, Yuriko Fukuda, Ryutaro Morita, Yuki Ishikawa, Tomohiko Kanaoka, Yoshiyuki Toya, Yohei Kirino, Hiromichi Wakui, Kouichi Tamura   +10 more
doaj   +1 more source